Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Recombinant vs Egg-based Influenza Vaccines in HCP
NCT04523324Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Oct 2019
- Primary completion
- Jan 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine, recombinant hemagglutinin in influenza, sponsored by Centers for Disease Control and Prevention. Started Oct 2019; status: completed.
02
Drugs
influenza vaccine, recombinant hemagglutinin
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04523324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04523324.